NCT01413048

Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension

Phase III Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 Versus Carvedilol in Patient With Stage 1 to 2 Essential Hypertension

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 260 (estimated)
• Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the antihypertensive effect of AGSCT101 tablet in patient with stage 1 to 2 essential hypertension.

Detailed description

This study is 2,8 weeks, multi-center, randomized, double-blind, active clinical trial to evaluate the efficacy and safety of AGSCT101 versus Carvedilol in patient with stage 1 to 2 essential hypertension.

Conditions

• Essential Hypertension

Interventions

Type	Name	Description
DRUG	Carvedilol 25mg	Tablet, q.d.
DRUG	AGSCT101 12.5mg	Tablet, q.d.

Timeline

• Start date: 2011-01-01
• Primary completion: 2012-03-01
• Completion: 2012-09-01
• First posted: 2011-08-10
• Last updated: 2011-08-10

Locations

1 site across 1 country: South Korea